MSDS - CLIAwaived.com

Material Safety Data SheetMSDS: 206034 Effective Date: March 31, 2003SECTION I - PRODUCT IDENTIFICATION AND COMPANYProduct Name:3-PD Hematology Control (Low Level, Normal Level, High Level)Synonyms:Whole blood reference controlNIOSH/RTECS Number: NoneCAS No.:NoneProduct Number(s): 502-004, 502-012, 502-013, 502-014, 502-015, 502-016, 502-017,502-023, 502-024, 502-025Manufacturer:Clinical Diagnostic Solutions, Inc.1800 Northwest 65 th AvenuePlantation, FL 33313 USAEMERGENCY PHONE: (954) 791-1773SECTION II - INGREDIENTSComponent Concentration CAS NumberStabilized human erythrocytes 10 – 55% NoneSECTION III – HAZARDS IDENTIFICATIONCDS Safety Information:Code[1] Health 0 = None[0] Flammability 1 = Slight[0] Reactivity 2 = Caution[1] Contact 3 = SeverePhysical Hazards:None known.Potential Health Effects: See Section XI. for detailed health effects.Product Hazard Classification: OSHA – Not applicableEU – Not applicableWHMIS – ExemptSECTION IV – FIRST AID MEASURESEye Contact:Ingestion:Inhalation:Skin Contact:Flush eyes thoroughly with water for at least 15 minutes. If irritationoccurs, seek medical attention.If ingested, wash mouth with water. Contact poison control center orseek medical attention if swallowed.Move exposed individual to fresh air. If individual is not breathing,begin artificial respiration immediately. Seek medical attention.Wash affected area with soap and water for at least 15 minutes.Disinfect if possible.SECTION V - FIRE AND EXPLOSION HAZARD DATAFlashpoint:Flammable Limits:Autoignition Temperature:Not applicable.Not applicable.Not applicable.206034A MSDS – 3-PD Hematology Control Page 1 of 3Rev. Date: March 31, 2003

SECTION V - FIRE AND EXPLOSION HAZARD DATA (Continued)Fire Extinguishing Media:Special Fire and Explosion Hazards:Hazardous Combustion Products:Firefighter Protective Equipment:Any. Does not support combustion.None.None.Self-contained breathing apparatus.SECTION VI – ACCIDENTAL RELEASE MEASURESPersonal Precautions:Spills and Leaks:Environmental Precautions:No special precautions required. Use universal precautionsduring cleanup.Treat with bleach diluted 1:10, then use absorbent materialand dispose as non-hazardous solid waste. Dispose liquidmaterial through a sanitary sewer. Disposal must comply withFederal, State and Local requirements.Contain spill to prevent contamination of surrounding areas.SECTION VII - HANDLING AND STORAGE PRECAUTIONSHandling Precautions:Storage Conditions:Follow universal precautions when using this product. Handleas if capable of transmitting infectious disease.Store according to package instructions.SECTION VIII – EXPOSURE CONTROL AND PERSONAL PROTECTIONExposure Limits:Engineering Controls:Respiratory Protection:Eye Protection:Skin Protection:OSHA – None established.ACGIH – None established.DFG MAK – None established.Use in well ventilated areas.Under normal use conditions, none required.Safety glasses, goggles or face shield recommended.Latex or equivalent gloves recommended.SECTION IX – PHYSICAL AND CHEMICAL PROPERTIESBoiling Point: N/A Vapor Pressure (mm Hg): N/AMelting Point: N/A Vapor Density (Air = 1): N/ASpecific Gravity: 1.05 (Water = 1) Evaporation RateSolubility (water): Miscible (butyl acetate = 1): N/AAppearance and Color: Red, opaque suspension pH: 6.3 – 6.8SECTION X - REACTIVITY DATAStability:Conditions to Avoid:Hazardous Incompatibility:Decomposition Products:Stable at normal temperatures and pressures.Avoid freezing. Keep away from incompatible materials.Strong acids, oxidizers, metals and metallic compounds.No known hazardous decomposition products.SECTION XI – TOXICOLOGICAL INFORMATIONToxicity of Hazardous Ingredients:Primary Routes of Exposure:Effects of Acute Exposure:Not available.Contact with eyes, mucous membranes, skin and inhalation.This product contains materials of human and non-humanorigin and may be capable of transmitting infectious diseases.Full toxicological properties have not been determined for thisproduct.SECTION XI – TOXICOLOGICAL INFORMATION (Continued)206034A MSDS – 3-PD Hematology Control Page 2 of 3Rev. Date: March 31, 2003

Effects of Chronic Exposure:Symptoms of Overexposure:Carcinogenicity:Other Effects:Conditions Aggravated by Exposure:Similar to effects of acute exposure.None identified.Contains no ingredients listed as potential carcinogens byACGIH, IARC, NTP or OSHA.None known.None known.SECTION XII – ECOLOGICAL INFORMATIONEcotoxicity:Biodegradability:Mobility:No information available.No information available.No information available.SECTION XIII – WASTE DISPOSALWaste Disposal:Waste disposal must comply with Federal, State and Localrequirements. Contact local authorities for information.SECTION XIV – TRANSPORT INFORMATIONTransport Regulations:Transportation of this product not regulated according to thedefinition of hazardous in 49CFR (US DOT). Transportationof this product is also not regulated by IATA, ICAO,Canadian TDG or European ADR.SECTION XV – REGULATORY INFORMATIONUS Regulatory Information:SARA 313:None listed.CIRCLA RG’s:Sodium phosphate, dibasic is listed.California Proposition 65: No compounds listed.Massachusetts MSL:Sodium phosphate, dibasic is listed.New Jersey Dept. of Health RTK: Sodium phosphate, dibasic is listed.Pennsylvania RTK:Sodium phosphate, dibasic is listed.Florida Substance List:None listed.Canada:Product is exempt from WHMIS and MSDS requirements.Ingredients on Disclosure List: Citric acid, glutaraldehyde, iodoacetamide.Ingredients with UnknownToxicological Properties:Exempt product.EU:Not classified.SECTION XVI – OTHER INFORMATIONFor further information, please contact Clinical Diagnostic Solutions, Inc.Clinical Diagnostic Solutions, Inc. believes the information contained herein to be valid and accurate. Nowarranties or representations are made or implied as to its validity, accuracy or currency. ClinicalDiagnostic Solutions, Inc. shall not be liable or otherwise responsible in any way for the use of thisinformation. Disposal of hazardous materials may be subject to local laws or regulation.206034A MSDS – 3-PD Hematology Control Page 3 of 3Rev. Date: March 31, 2003